vs
DigitalBridge Group, Inc.（DBRG）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是DigitalBridge Group, Inc.的2.0倍（$207.3M vs $105.7M），DigitalBridge Group, Inc.净利率更高（61.5% vs -62.0%，领先123.5%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 4.1%），DigitalBridge Group, Inc.自由现金流更多（$258.0M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 19.2%）
DigitalBridge Group（DBRG）是全球领先的数字基础设施投资企业，核心业务覆盖通信基站、数据中心、光纤网络、小基站及边缘算力设施的投资、持有与运营。公司总部位于美国博卡拉顿，在洛杉矶、纽约、丹佛、伦敦、新加坡多地设有办公点，截至2025年6月，旗下管理资产规模达1060亿美元。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
DBRG vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $105.7M | $207.3M |
| 净利润 | $65.1M | $-128.6M |
| 毛利率 | — | — |
| 营业利润率 | — | -54.7% |
| 净利率 | 61.5% | -62.0% |
| 营收同比 | 4.1% | 25.9% |
| 净利润同比 | — | 3.5% |
| 每股收益（稀释后） | $0.28 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $105.7M | $207.3M | ||
| Q3 25 | $93.3M | $159.9M | ||
| Q2 25 | $85.3M | $166.5M | ||
| Q1 25 | $90.1M | $139.3M | ||
| Q4 24 | $101.6M | $164.6M | ||
| Q3 24 | $76.6M | $139.5M | ||
| Q2 24 | $390.3M | $147.0M | ||
| Q1 24 | $74.4M | $108.8M |
| Q4 25 | $65.1M | $-128.6M | ||
| Q3 25 | $31.4M | $-180.4M | ||
| Q2 25 | $31.6M | $-115.0M | ||
| Q1 25 | $13.8M | $-151.1M | ||
| Q4 24 | — | $-133.2M | ||
| Q3 24 | $13.8M | $-133.5M | ||
| Q2 24 | $91.4M | $-131.6M | ||
| Q1 24 | $-29.6M | $-170.7M |
| Q4 25 | — | -54.7% | ||
| Q3 25 | -13.9% | -106.9% | ||
| Q2 25 | -31.2% | -64.8% | ||
| Q1 25 | -11.5% | -102.6% | ||
| Q4 24 | 5.7% | -74.3% | ||
| Q3 24 | 62.4% | -94.6% | ||
| Q2 24 | 33.5% | -79.1% | ||
| Q1 24 | -20.7% | -151.9% |
| Q4 25 | 61.5% | -62.0% | ||
| Q3 25 | 33.7% | -112.8% | ||
| Q2 25 | 37.1% | -69.0% | ||
| Q1 25 | 15.3% | -108.5% | ||
| Q4 24 | — | -80.9% | ||
| Q3 24 | 18.0% | -95.7% | ||
| Q2 24 | 23.4% | -89.5% | ||
| Q1 24 | -39.8% | -156.8% |
| Q4 25 | $0.28 | $-1.28 | ||
| Q3 25 | $0.09 | $-1.81 | ||
| Q2 25 | $0.10 | $-1.17 | ||
| Q1 25 | $-0.01 | $-1.57 | ||
| Q4 24 | — | $-1.34 | ||
| Q3 24 | $-0.01 | $-1.40 | ||
| Q2 24 | $0.44 | $-1.52 | ||
| Q1 24 | $-0.28 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $382.5M | $421.0M |
| 总债务越低越好 | $298.8M | — |
| 股东权益账面价值 | $2.1B | $-80.0M |
| 总资产 | $3.4B | $1.5B |
| 负债/权益比越低杠杆越低 | 0.14× | — |
8季度趋势，按日历期对齐
| Q4 25 | $382.5M | $421.0M | ||
| Q3 25 | $358.4M | $202.5M | ||
| Q2 25 | $340.7M | $176.3M | ||
| Q1 25 | $349.9M | $127.1M | ||
| Q4 24 | $302.2M | $174.0M | ||
| Q3 24 | $294.4M | $150.6M | ||
| Q2 24 | $261.2M | $480.7M | ||
| Q1 24 | $247.4M | $112.3M |
| Q4 25 | $298.8M | — | ||
| Q3 25 | $327.9M | — | ||
| Q2 25 | $298.0M | — | ||
| Q1 25 | $296.9M | — | ||
| Q4 24 | $296.4M | — | ||
| Q3 24 | $295.8M | — | ||
| Q2 24 | $295.3M | — | ||
| Q1 24 | $366.5M | — |
| Q4 25 | $2.1B | $-80.0M | ||
| Q3 25 | $2.1B | $9.2M | ||
| Q2 25 | $2.0B | $151.3M | ||
| Q1 25 | $2.0B | $144.2M | ||
| Q4 24 | $2.0B | $255.0M | ||
| Q3 24 | $2.0B | $346.8M | ||
| Q2 24 | $2.0B | $432.4M | ||
| Q1 24 | $1.8B | $140.3M |
| Q4 25 | $3.4B | $1.5B | ||
| Q3 25 | $3.5B | $1.2B | ||
| Q2 25 | $3.4B | $1.3B | ||
| Q1 25 | $3.4B | $1.3B | ||
| Q4 24 | $3.5B | $1.5B | ||
| Q3 24 | $3.5B | $1.5B | ||
| Q2 24 | $3.5B | $1.6B | ||
| Q1 24 | $3.5B | $1.3B |
| Q4 25 | 0.14× | — | ||
| Q3 25 | 0.16× | — | ||
| Q2 25 | 0.15× | — | ||
| Q1 25 | 0.15× | — | ||
| Q4 24 | 0.15× | — | ||
| Q3 24 | 0.15× | — | ||
| Q2 24 | 0.15× | — | ||
| Q1 24 | 0.20× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $259.3M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $258.0M | $-100.8M |
| 自由现金流率自由现金流/营收 | 244.0% | -48.6% |
| 资本支出强度资本支出/营收 | 1.3% | 0.5% |
| 现金转化率经营现金流/净利润 | 3.99× | — |
| 过去12个月自由现金流最近4个季度 | $440.5M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $259.3M | $-99.8M | ||
| Q3 25 | $56.5M | $-91.4M | ||
| Q2 25 | $77.0M | $-108.3M | ||
| Q1 25 | $50.3M | $-166.5M | ||
| Q4 24 | $60.1M | $-79.3M | ||
| Q3 24 | $35.9M | $-67.0M | ||
| Q2 24 | $22.5M | $-77.0M | ||
| Q1 24 | $-27.0M | $-190.7M |
| Q4 25 | $258.0M | $-100.8M | ||
| Q3 25 | $56.1M | $-92.7M | ||
| Q2 25 | $76.4M | $-110.7M | ||
| Q1 25 | $50.0M | $-167.8M | ||
| Q4 24 | $56.5M | $-79.5M | ||
| Q3 24 | — | $-68.6M | ||
| Q2 24 | $22.3M | $-79.0M | ||
| Q1 24 | $-30.1M | $-193.9M |
| Q4 25 | 244.0% | -48.6% | ||
| Q3 25 | 60.2% | -58.0% | ||
| Q2 25 | 89.5% | -66.5% | ||
| Q1 25 | 55.5% | -120.5% | ||
| Q4 24 | 55.7% | -48.3% | ||
| Q3 24 | — | -49.2% | ||
| Q2 24 | 5.7% | -53.7% | ||
| Q1 24 | -40.4% | -178.2% |
| Q4 25 | 1.3% | 0.5% | ||
| Q3 25 | 0.4% | 0.8% | ||
| Q2 25 | 0.7% | 1.5% | ||
| Q1 25 | 0.3% | 1.0% | ||
| Q4 24 | 3.5% | 0.1% | ||
| Q3 24 | 0.0% | 1.2% | ||
| Q2 24 | 0.1% | 1.4% | ||
| Q1 24 | 4.1% | 3.0% |
| Q4 25 | 3.99× | — | ||
| Q3 25 | 1.80× | — | ||
| Q2 25 | 2.43× | — | ||
| Q1 25 | 3.65× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.61× | — | ||
| Q2 24 | 0.25× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DBRG
暂无分部数据
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
